An RPA-CRISPR-Cas12a-Based Fluorescence and Lateral Flow Assay for the Detection of Ureaplasma urealyticum

In the quiet corners of the human body, specifically within the urogenital tract, a microscopic organism called Ureaplasma urealyticum often lives unnoticed. For many, it causes no trouble, but for others, it acts as an opportunistic invader, leading to painful inflammation, infections that do not respond to standard treatments, and complications during pregnancy. Detecting this tiny pathogen has long been a struggle for doctors. Traditional methods require growing the bacteria in a lab, a process that can take days and often misses the target entirely. Other techniques, which look for the genetic code of the bug, are faster and more accurate but demand expensive, complex machines that only exist in well-equipped laboratories. This gap between what is needed and what is available leaves many patients without a quick or reliable diagnosis, especially in community clinics or remote areas where resources are scarce.

Scientists have been working to bridge this gap by combining two powerful biological tools. The first is a method that makes copies of a specific piece of genetic material, acting like a photocopier for DNA, but one that works at a steady, warm temperature rather than requiring the rapid heating and cooling cycles of traditional machines. The second tool is a molecular system derived from the immune defenses of bacteria, which acts like a highly precise search engine. Once this system finds its specific target, it switches on a powerful cutting ability that can be seen with the naked eye or measured by a simple light detector. By weaving these two technologies together, researchers have created a new way to find Ureaplasma urealyticum that is fast, sensitive, and does not need a laboratory full of expensive equipment.

A team of researchers at the Second Hospital of Hebei Medical University in China recently put this idea to the test. They designed a two-step process to hunt down the genetic signature of the bacteria. First, they took a sample and used the copying method to multiply any DNA from the target bacteria present in the fluid. This step took about twenty minutes and happened at a constant, mild warmth. Once the genetic material was amplified, they introduced the second tool: a protein complex guided by a specific RNA molecule. This complex was programmed to recognize only the copied DNA from the bacteria. If the bacteria were present, the complex would lock onto the target and immediately begin to slice through a special reporter molecule floating in the solution.

The researchers built two different ways to see the result of this slicing. The first method used a fluorescent reporter, a molecule that glows when cut. When the bacteria were present, the cutting action separated the glowing part from its dark partner, causing the solution to light up. This version of the test was incredibly sensitive, able to detect as few as three copies of the bacterial genetic material in a single drop of liquid. The second method was designed for places without any electricity or machines. Here, the reporter molecule was attached to a tiny gold particle and placed on a strip of paper, similar to a home pregnancy test. If the bacteria were present, the cutting action released the gold particles, which then traveled up the strip and formed a visible red line. This visual version was slightly less sensitive, detecting about sixty-six copies per drop, but it required no instruments to read the result.

To ensure the test was reliable, the team checked if it would mistake other common infections for the target bacteria. They tested samples containing four different types of urogenital pathogens, including those that cause gonorrhea and chlamydia. The new test remained silent for all of them, showing that it would not trigger a false alarm. The researchers then took thirty real samples from patients and compared their new method against a standard commercial test used in hospitals. The results were a perfect match; the new system identified every positive case and every negative case exactly as the standard method did.

The entire process, from adding the sample to seeing the result, took between thirty-five and fifty minutes. This is a significant improvement over the days required for bacterial culture and the specialized equipment needed for standard genetic testing. The ability to perform this test using only a simple heater and, in the visual version, no machines at all, suggests a new path for diagnosing difficult infections in settings where advanced technology is unavailable. By proving that this combination of copying and cutting works so well for Ureaplasma urealyticum, the researchers have shown that rapid, accurate diagnosis can be brought out of the high-tech lab and into the hands of clinicians everywhere.